4.0126
0.57%
0.0226
시간 외 거래:
4.01
-0.0026
-0.06%
Xenetic Biosciences Inc (XBIO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
23.98%
0.5108
|
0.672 | 0.6112 | 0.651 | 0.6058 |
Operating Expenses
|
7.70%
1.7792
|
1.9276 | 1.7579 | 1.8492 | 1.521 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
7.70%
1.7792
|
1.9276 | 1.7579 | 1.8492 | 1.521 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
1.02%
-1.2684
|
-1.2557 | -1.1467 | -1.1982 | -0.9152 |
Net Interest Income/Expense |
12.55%
0.0732
|
0.0838 | 0.0918 | 0.1261 | 0.0541 |
Nonoperating Income/Loss |
12.90%
0.0733
|
0.0842 | 0.0911 | 0.1472 | 0.0586 |
Income/Loss From Continuing Operations Before Tax |
23.98%
0.5108
|
0.672 | 0.6112 | 0.651 | 0.6058 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
2.02%
-1.1951
|
-1.1715 | -1.0556 | -1.051 | -0.8566 |
Net Income/Loss
|
2.02%
-1.1951
|
-1.1715 | -1.0556 | -1.051 | -0.8566 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
44,008%
1.5407
|
0.00349 | 1.5326 | 1.5247 | 15.17 |
Diluted Average Shares |
44,008%
1.5407
|
0.00349 | 1.5326 | 1.5247 | 15.17 |
Basic Earnings Per Share |
1.30%
-0.78
|
-0.77 | -0.69 | -0.69 | -0.06 |
Diluted Earnings Per Share |
1.30%
-0.78
|
-0.77 | -0.69 | -0.69 | -0.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):